These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 23902796
1. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z. BMC Cancer; 2013 Jul 31; 13():366. PubMed ID: 23902796 [Abstract] [Full Text] [Related]
3. High expression of DEK predicts poor prognosis of gastric adenocarcinoma. Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z. Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035 [Abstract] [Full Text] [Related]
4. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma. Liu X, Qi D, Qi J, Mao Z, Li X, Zhang J, Li J, Gao W. Oncol Rep; 2016 Jan 20; 35(1):155-62. PubMed ID: 26530274 [Abstract] [Full Text] [Related]
5. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Sun J, Bi F, Yang Y, Zhang Y, Jin A, Li J, Lin Z. Oncol Rep; 2017 Feb 20; 37(2):857-864. PubMed ID: 27959420 [Abstract] [Full Text] [Related]
6. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. Martinez-Useros J, Rodriguez-Remirez M, Borrero-Palacios A, Moreno I, Cebrian A, Gomez del Pulgar T, del Puerto-Nevado L, Vega-Bravo R, Puime-Otin A, Perez N, Zazo S, Senin C, Fernandez-Aceñero MJ, Soengas MS, Rojo F, Garcia-Foncillas J. BMC Cancer; 2014 Dec 16; 14():965. PubMed ID: 25515240 [Abstract] [Full Text] [Related]
9. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer. Hou M, Huang R, Song Y, Feng D, Jiang Y, Liu M. Jpn J Clin Oncol; 2016 Mar 16; 46(3):222-7. PubMed ID: 26819280 [Abstract] [Full Text] [Related]
11. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients. Zhu J, Chen X, Liao Z, He C, Hu X. Int J Clin Exp Pathol; 2015 Mar 16; 8(1):702-10. PubMed ID: 25755764 [Abstract] [Full Text] [Related]
14. DEK: A novel early screening and prognostic marker for breast cancer. Ying G, Wu Y. Mol Med Rep; 2015 Nov 16; 12(5):7491-5. PubMed ID: 26459608 [Abstract] [Full Text] [Related]
15. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J. BMC Cancer; 2018 Feb 06; 18(1):144. PubMed ID: 29409457 [Abstract] [Full Text] [Related]
16. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma. Yi HC, Liu YL, You P, Pan JS, Zhou JY, Liu ZJ, Zhang ZY. Mol Med Rep; 2015 Feb 06; 11(2):1318-23. PubMed ID: 25351213 [Abstract] [Full Text] [Related]
17. Clinical implications of high NQO1 expression in breast cancers. Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, Chen L. J Exp Clin Cancer Res; 2014 Feb 05; 33(1):14. PubMed ID: 24499631 [Abstract] [Full Text] [Related]
18. [Relationship between DEK oncogene expression and oral squamous cell carcinoma]. Wang X, Huang SH, Yu LQ, Liu J, Diao Y, Sun CF. Shanghai Kou Qiang Yi Xue; 2014 Feb 05; 23(1):75-9. PubMed ID: 24608617 [Abstract] [Full Text] [Related]
20. Expression of MSP58 in human colorectal cancer and its correlation with prognosis. Shi H, Li SJ, Zhang B, Liu HL, Chen CS. Med Oncol; 2012 Dec 05; 29(5):3136-42. PubMed ID: 22773039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]